                               SEQUENCE LISTING	

<110> EMPIRE TECHNOLOGIES
 
<120> COMPOSITIONS AND METHODS FOR CONTROLLABLY DELIVERING AN AGENT

<130> 091619-0424

<140>
<141>

<160> 4     

<170> PatentIn version 3.5

<210> 1
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
His Ala Ile Tyr Pro Arg His 
1               5           


<210> 2
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 2
Leu Arg Lys Leu Arg Lys Arg Leu Leu Arg Asp Ala Asp Asp Leu Leu 
1               5                   10                  15      


Arg Lys Leu Arg Lys Arg Leu Leu Arg Asp Ala Asp Asp Leu 
            20                  25                  30  


<210> 3
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(3)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Gly or Ser

<400> 3
Glu Xaa Xaa Tyr Xaa Gln Xaa 
1               5           


<210> 4
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Arg Gly Asp Ser 
1               


